CL
Insider
Column Group IV GP, LP
10% ownerColumn Group IV GP, LP (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in Eikon Therapeutics, Inc. (EIKN). Across 1 priced purchase filing, the average 21-session return was -2.0% from execution and -11.7% from disclosure (delay-adjusted; derived). The largest single filing was $38.1M of EIKN (2,117,760 sh across 3 lots, as filed), executed Feb 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-2.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-11.7%
same 1 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$39.2M
shares × price, as filed
Last traded
Sep 3
Filed Sep 8
Median ADV $4.4M across their filed names
50% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $39.2M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
EIKNRecent filings
EIKNPURCHASE
Eikon Therapeutics, Inc.
View filing →
$1.0M89,200 sh × $11.56
Exec Sep 3
Filed Sep 8 · 4:33 PM ET EIKNPURCHASE Eikon Therapeutics, Inc. View filing → $38.1M
2,117,760 sh across 3 lots
Exec Feb 6
Filed Feb 9 · 9:19 PM ET